CVE-2000-1134

CVE-2000-1134 is a high-severity vulnerability in Immunix with a CVSS 2.0 base score of 7.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

Multiple shell programs on various Unix systems, including (1) tcsh, (2) csh, (3) sh, and (4) bash, follow symlinks when processing << redirects (aka here-documents or in-here documents), which allows local users to overwrite files of other users via a symlink attack.

Frequently asked questions

What is CVE-2000-1134?
Multiple shell programs on various Unix systems, including (1) tcsh, (2) csh, (3) sh, and (4) bash, follow symlinks when processing << redirects (aka here-documents or in-here documents), which allows local users to overwrite files of other users via a symlink attack.
How severe is CVE-2000-1134?
CVE-2000-1134 has a CVSS 2.0 base score of 7.2, rated high severity.
Is CVE-2000-1134 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (70th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2000-1134?
CVE-2000-1134 primarily affects Immunix. In total, 22 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2000-1134?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2000-1134 published?
CVE-2000-1134 was published on 2001-01-09 and last updated on 2026-06-16.

References

Affected products (22)

More vulnerabilities in Immunix

All CVEs affecting Immunix →